Literature DB >> 2442272

Multiple class I molecules generated from single genes by alternative splicing of pre-mRNAs.

A M Lew, J McCluskey, W L Maloy, D H Margulies, J E Coligan.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2442272     DOI: 10.1007/bf02918108

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  68 in total

Review 1.  On the origin of RNA splicing and introns.

Authors:  P A Sharp
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

2.  The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein.

Authors:  B Chabot; D L Black; D M LeMaster; J A Steitz
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs.

Authors:  R A Young; O Hagenbüchle; U Schibler
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

4.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

5.  Lens crystallins and their gene families.

Authors:  J Piatigorsky
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

6.  DNA sequence of a gene encoding a BALB/c mouse Ld transplantation antigen.

Authors:  K W Moore; B T Sher; Y H Sun; K A Eakle; L Hood
Journal:  Science       Date:  1982-02-05       Impact factor: 47.728

7.  Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes.

Authors:  M Fehlmann; J F Peyron; M Samson; E Van Obberghen; D Brandenburg; N Brossette
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  H-2K molecules have two different C-termini, one of which is K-region specific.

Authors:  W L Maloy; A M Lew; R W Anderson; J E Coligan
Journal:  Mol Immunol       Date:  1988-05       Impact factor: 4.407

9.  Intron sequences involved in lariat formation during pre-mRNA splicing.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

10.  Alternative RNA splicing generates transcripts encoding a thorax-specific isoform of Drosophila melanogaster myosin heavy chain.

Authors:  S I Bernstein; C J Hansen; K D Becker; D R Wassenberg; E S Roche; J J Donady; C P Emerson
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

View more
  6 in total

1.  Transmembrane and cytoplasmic domain sequences demonstrate at least two expressed bovine MHC class I loci.

Authors:  S A Ellis; K A Braem; W I Morrison
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Haplotype characterization of transcribed ovine major histocompatibility complex (MHC) class I genes.

Authors:  Despoina Miltiadou; Keith T Ballingall; Shirley A Ellis; George C Russell; Declan J McKeever
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

3.  Class I major histocompatibility complex cDNA clones from sheep thymus: alternative splicing could make a long cytoplasmic tail.

Authors:  D Grossberger; W Hein; A Marcuz
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Signals controlling alternative splicing of major histocompatibility complex H-2 class I pre-mRNA.

Authors:  D E Handy; J McCluskey; A M Lew; J E Coligan; D H Margulies
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  A novel H-2K splice form: predictions for other alternative H-2 splicing events.

Authors:  J M Vogel; R Y Morse; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Adenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins.

Authors:  R Lippé; E Luke; Y T Kuah; C Lomas; W A Jefferies
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.